Search Results - Steven R. Zeldenrust
- Showing 1 - 20 results of 65
- Go to Next Page
-
1
-
2
-
3
Reduction in C‐reactive protein indicates successful targeting of the IL‐1/IL‐6 axis resulting in improved survival in early stage multiple myeloma by John A. Lust, Martha Q. Lacy, Steven R. Zeldenrust, Thomas E. Witzig, Laurie L. Moon‐Tasson, Charles A. Dinarello, Kathleen A. Donovan
Published 2016Artigo -
4
Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma by Sumit Madan, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, S. Vincent Rajkumar, Morie A. Gertz, Shaji Kumar
Published 2010Artigo -
5
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics by Julie A. Vrana, Jason D. Theis, Surendra Dasari, Oana Madalina Mereuta, Angela Dispenzieri, Steven R. Zeldenrust, MA Gertz, Paul J. Kurtin, Karen L. Grogg, Ahmet Doǧan
Published 2014Artigo -
6
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry by Taxiarchis Kourelis, Surendra Dasari, Jason D. Theis, Marina Ramı́rez-Alvarado, Paul J. Kurtin, Morie A. Gertz, Steven R. Zeldenrust, Roman M. Zenka, Ahmet Doǧan, Angela Dispenzieri
Published 2016Artigo -
7
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System by Martha Grogan, Christopher G. Scott, Robert A. Kyle, Steven R. Zeldenrust, Morie A. Gertz, Grace Lin, Kyle W. Klarich, Wayne L. Miller, Joseph J. Maleszewski, Angela Dispenzieri
Published 2016Artigo -
8
Changes in serum‐free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis by Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, Tow Shung Tan, Shirshendu Sinha, Nelson Leung, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Published 2010Artigo -
9
Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction by Selma F. Mohammed, Sultan A. Mirzoyev, William D. Edwards, Ahmet Doǧan, Donna R. Grogan, Shannon M. Dunlay, Véronique L. Roger, Morie A. Gertz, Angela Dispenzieri, Steven R. Zeldenrust, Margaret M. Redfield
Published 2014Artigo -
10
Mass Spectrometric–Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue by Christopher J. Klein, Julie A. Vrana, Jason D. Theis, P. James B. Dyck, P. James B. Dyck, Robert J. Spinner, Michelle L. Mauermann, H. Robert Bergen, Steven R. Zeldenrust, Ahmet Doǧan
Published 2010Artigo -
11
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma by Sumit Madan, Martha Q. Lacy, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Kristen Detweiler‐Short, David Dingli, Steven R. Zeldenrust, John A. Lust, Philip R. Greipp, S. Vincent Rajkumar, Shaji Kumar
Published 2011Artigo -
12
Improved survival in multiple myeloma and the impact of novel therapies by Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, David Dingli, Stephen J. Russell, John A. Lust, Philip R. Greipp, Robert A. Kyle, Morie A. Gertz
Published 2007Artigo -
13
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney by Morie A. Gertz, Nelson Leung, M. Q. Lacy, Angela Dispenzieri, Steven R. Zeldenrust, S. R. Hayman, Francis K. Buadi, D. Dingli, Philip R. Greipp, Shaji Kumar, John A. Lust, S. Vincent Rajkumar, Stephen J. Russell, T. E. Witzig
Published 2009Artigo -
14
Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2 by Bonnie K. Arendt, Marina Ramı́rez-Alvarado, Laura A. Sikkink, Jonathan J. Keats, Gregory Ahmann, Angela Dispenzieri, Rafaël Fonseca, Rhett P. Ketterling, Ryan A. Knudson, Erin M. Mulvihill, Renee C. Tschumper, Xiaosheng Wu, Steven R. Zeldenrust, Diane F. Jelinek
Published 2008Artigo -
15
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis by Angela Dispenzieri, Martha Q. Lacy, Steven R. Zeldenrust, Suzanne R. Hayman, Shaji Kumar, Susan M. Geyer, John A. Lust, Jacob B. Allred, Thomas E. Witzig, S. Vincent Rajkumar, Philip R. Greipp, Stephen J. Russell, Brian Kabat, Morie A. Gertz
Published 2006Artigo -
16
Clinical implication of centrosome amplification in plasma cell neoplasm by Wee Joo Chng, Greg Ahmann, Kim Henderson, Rafael Santana‐Davila, Philip R. Greipp, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, S. Vincent Rajkumar, John A. Lust, Robert A. Kyle, Steven R. Zeldenrust, Suzanne R. Hayman, Rafaël Fonseca
Published 2005Artigo -
17
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis by Gregory P. Kaufman, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Nelson Leung, David Dingli, John A. Lust, Yi Lin, Prashant Kapoor, Ronald S. Go, Steven R. Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
Published 2014Artigo -
18
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients by Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Shivlal Pandey, Prashant Kapoor, David Dingli, Suzanne R. Hayman, Nelson Leung, John A. Lust, Arleigh McCurdy, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar
Published 2013Artigo -
19
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis by Wilson I. Gonsalves, S. Vincent Rajkumar, Ronald S. Go, Angela Dispenzieri, Vinay Gupta, Preet Paul Singh, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, David Dingli, John A. Lust, Steven R. Zeldenrust, Suzanne R. Hayman, Robert A. Kyle, Morie A. Gertz, Shaji Kumar
Published 2014Artigo -
20
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis by Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, Martha Q. Lacy, Mary F. Burritt, Terry M. Therneau, Philip R. Greipp, Thomas E. Witzig, John A. Lust, S. Vincent Rajkumar, Rafaël Fonseca, Steven R. Zeldenrust, Christopher G.A. McGregor, Allan S. Jaffe
Published 2004Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Multiple myeloma
Gastroenterology
Immunology
Antibody
Surgery
Amyloidosis
Immunoglobulin light chain
Oncology
AL amyloidosis
Biology
Dexamethasone
Lenalidomide
Pathology
Autologous stem-cell transplantation
Chemotherapy
Disease
Transplantation
Cohort
Confidence interval
Intensive care medicine
Pomalidomide
Hazard ratio
Heart failure
Paleontology
Polyneuropathy
Thalidomide
Transthyretin
Urology